Skip to main content
FDA allows continued sale of breast implants linked to cancer
5/6/2019

The FDA announced it will permit continued sales of textured breast implants, which were recently tied to breast-implant-associated anaplastic large cell lymphoma. However, the agency may consider adding a black box warning and is working with patient groups and manufacturers on label changes.

Full Story: